Cell stress induced by the parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation

Antioxidants and Redox Signaling

Volumn 9, Issue 12, 2007, Pages 2255-2264

  Kim Han, Jeong Sook ^a   O'Malley, Karen L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CHAPERONE; DEOXYRIBONUCLEASE; GLUTATHIONE; HYDROGEN PEROXIDE; MITOCHONDRIAL DNA; OXIDOPAMINE; PROTEIN DISULFIDE ISOMERASE; PROTEIN ERP57; REACTIVE OXYGEN METABOLITE; ROTENONE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL STRESS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; MOUSE; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; CELL LINE, TRANSFORMED; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DEOXYRIBONUCLEASES; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MOLECULAR CHAPERONES; MOLECULAR WEIGHT; NEURONS; OXIDATION-REDUCTION; OXIDOPAMINE; PARKINSON DISEASE; PROTEIN DENATURATION; PROTEIN DISULFIDE-ISOMERASE; RIBONUCLEASES; STRESS; SUBCELLULAR FRACTIONS;

PARKINSONIA;

EID: 35848965047     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1791     Document Type: Article

References (48)

1. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803, 2002.
2. Celli CM and Jaiswal AK. Role of GRP58 in mitomycin C-induced DNA cross-linking. Cancer Res 63: 6016-6025, 2003.
3. Chichiarelli S, Ferraro A, Altieri F, Eufemi M, Coppari S, Grillo C, Arcangeli V, and Turano C. The stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cells. J Cell Physiol 210: 343-351, 2007.
4. Choi HK, Won L, Roback JD, Wainer BH, and Heller A. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc Natl Acad Sci U S A 89: 8943-8947, 1992.
5. Choi J, Malakowsky CA, Talent JM, Conrad CC, Carroll CA, Weintraub ST, and Gracy RW. Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts. Biochim Biophys Acta 1637: 135-141, 2003.
6. Coppari S, Altieri F, Ferraro A, Chichiarelli S, Eufemi M, and Turano C. Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J Cell Biochem 85: 325-333, 2002.
7. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, and Milzani A. Protein carbonylation in human diseases. Trends Mol Med 9: 169-176, 2003.
8. Falcon-Perez JM, Nazarian R, Sabatti C, and Dell'Angelica EC. Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 118: 5243-5255, 2005.
9. Ferger B, Rose S, Jenner A, Halliwell B, and Jenner P. 6-Hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum. Neuroreport 12: 1155-1159, 2001.
10. Frickel EM, Frei P, Bouvier M, Stafford WF, Helenius A, Glockshuber R, and Ellgaard L. ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem 279: 18277-18287, 2004.
11. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, and Singleton A. Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60: 389-398, 2006.
12. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, and Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 25: 2793-802, 2005.
13. Holtz WA and O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278: 19367-19377, 2003.
14. Holtz WA, Turetzky JM, Jong YJ, and O'Malley KL. Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J Neurochem 99: 54-69, 2006.
15. Holtz WA, Turetzky JM, and O'Malley KL. Microarray expression profiling identifies early signaling transcripts associated with 6-OHDA-induced dopaminergic cell death. Antioxid Redox Signal 7: 639-648, 2005.
16. Iwata A, Riley BE, Johnston JA, and Kopito RR. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280: 40282-40292, 2005.
17. Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, Shimohama S, and Akaike A. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 79:849-860, 2005.
18. Jensen PJ, Alter BJ, and O'Malley KL. Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J Neurochem 86: 196-209, 2003.
19. Jessop CE and Bulleid NJ. Glutathione directly reduces an oxidoreductase in the endoplasmic reticulum of mammalian cells. J Biol Chem 279: 55341-55347, 2004.
20. Jessop CE, Chakravarthi S, Watkins RH, and Bulleid NJ. Oxidative protein folding in the mammalian endoplasmic reticulum. Biochem Soc Trans 32: 655-658, 2004.
21. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530, 2000.
22. Laragione T, Gianazza E, Tonelli R, Bigini P, Mennini T, Casoni F, Massignan T, Bonetto V, and Ghezzi P. Regulation of redox-sensitive exofacial protein thiols in CHO cells. Biol Chem 387: 1371-1376, 2006.
23. Lee AS, Delegeane A, and Scharff D. Highly conserved glucose-regulated protein in hamster and chicken cells: preliminary characterization of its cDNA clone. Proc Natl Acad Sci U S A 78: 4922-4925, 1981.
24. Levay G, Ye Q, and Bodell WJ. Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine. Exp Neurol 146: 570-574, 1997.
25. Lotharius J, Dugan LL, and O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19:1284-1293, 1999.
26. Melero JA and Smith AE. Possible transcriptional control of three polypeptides which accumulate in a temperature-sensitive mammalian cell line. Nature 272: 725-727, 1978.
27. Meredith SC. Protein denaturation and aggregation: cellular responses to denatured and aggregated proteins. Ann N Y Acad Sci 1066: 181-221, 2005.
28. Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, Healy DG, Gilks WP, Lees AJ, Holton J, Revesz T, Parker PJ, Harvey RJ, Wood NW, and Latchman DS. Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98: 56-69, 2006.
29. Nagata E, Sawa A, Ross CA, and Snyder SH. Autophagosome-like vacuole formation in Huntington's disease lymphoblasts. Neuroreport 15: 1325-1328, 2004.
30. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, and Sehgal PB. Cellular physiology of STAT3: where's the cytoplasmic monomer? J Biol Chem 274: 25499-25509, 1999.
31. Nixon RA. Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 29: 528-535, 2006.
32. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 24: 1311-1317, 2005.
33. Paschen W and Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 38: 109-115, 2005.
34. Reverter-Branchat G, Cabiscol E, Tamarit J, and Ros J. Oxidative damage to specific proteins in replicative and chronological-aged Saccharomyces cerevisiae: common targets and prevention by calorie restriction. J Biol Chem 279: 31983-31989, 2004.
35. Rideout HJ, Lang-Rollin I, and Stefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int J Biochem Cell Biol 36: 2551-2562, 2004.
36. Ryu EJ, Angelastro JM, and Greene LA. Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol Dis 18: 54-74, 2005.
37. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, and Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 22: 10690-10698, 2002.
38. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, and Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med 42: 675-685, 2007.
39. Sekine Y, Takeda K, and Ichijo H. The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases. Curr Mol Med 6: 87-97, 2006.
40. Sharma M and Slocum HK. Prevention of quinone-mediated DNA arylation by antioxidants. Biochem Biophys Res Commun 262: 769-774, 1999.
41. Stokes AH, Hastings TG, and Vrana KE. Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55: 659-665, 1999.
42. Stone SJ and Vance JE. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J Biol Chem 275: 34534-34540, 2000.
43. Szegezdi E, Logue SE, Gorman AM, and Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7: 880-885, 2006.
44. Turano C, Coppari S, Altieri F, and Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 193: 154-163, 2002.
45. Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, and Wanker EE. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 12: 1393-1407, 2001.
46. Wang P, Song Y, Zhang L, He H, and Zhou X. Quinone methide derivatives: important intermediates to DNA alkylating and DNA cross-linking actions. Curr Med Chem 12: 2893-2913, 2005.
47. Wang X, Thomas B, Sachdeva R, Arterburn L, Frye L, Hatcher PG, Cornwell DG, and Ma J. Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proc Natl Acad Sci U S A 103: 3604-3609, 2006.
48. Williams DB. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci 119: 615-623, 2006.